Copyright Reports & Markets. All rights reserved.

Global Histamine H4 Receptor Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Histamine H4 Receptor Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Histamine H4 Receptor Market Size Growth Rate by Product
      • 1.4.2 GD-48
      • 1.4.3 JNJ-28307474
      • 1.4.4 UR-63325
      • 1.4.5 ZPL-389
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Histamine H4 Receptor Market Size Growth Rate by End User
      • 1.5.2 Asthma
      • 1.5.3 Cystic Fibrosis
      • 1.5.4 Atopic Dermatitis
      • 1.5.5 Hearing Disorders
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Histamine H4 Receptor Market Size
      • 2.1.1 Global Histamine H4 Receptor Revenue 2014-2025
      • 2.1.2 Global Histamine H4 Receptor Sales 2014-2025
    • 2.2 Histamine H4 Receptor Growth Rate by Regions
      • 2.2.1 Global Histamine H4 Receptor Sales by Regions
      • 2.2.2 Global Histamine H4 Receptor Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Histamine H4 Receptor Sales by Manufacturers
      • 3.1.1 Histamine H4 Receptor Sales by Manufacturers
      • 3.1.2 Histamine H4 Receptor Sales Market Share by Manufacturers
      • 3.1.3 Global Histamine H4 Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Histamine H4 Receptor Revenue by Manufacturers
      • 3.2.1 Histamine H4 Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Histamine H4 Receptor Revenue Share by Manufacturers (2014-2019)
    • 3.3 Histamine H4 Receptor Price by Manufacturers
    • 3.4 Histamine H4 Receptor Manufacturing Base Distribution, Product Types
      • 3.4.1 Histamine H4 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Histamine H4 Receptor Product Type
      • 3.4.3 Date of International Manufacturers Enter into Histamine H4 Receptor Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Histamine H4 Receptor Sales by Product
    • 4.2 Global Histamine H4 Receptor Revenue by Product
    • 4.3 Histamine H4 Receptor Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Histamine H4 Receptor Breakdown Data by End User

    6 North America

    • 6.1 North America Histamine H4 Receptor by Countries
      • 6.1.1 North America Histamine H4 Receptor Sales by Countries
      • 6.1.2 North America Histamine H4 Receptor Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Histamine H4 Receptor by Product
    • 6.3 North America Histamine H4 Receptor by End User

    7 Europe

    • 7.1 Europe Histamine H4 Receptor by Countries
      • 7.1.1 Europe Histamine H4 Receptor Sales by Countries
      • 7.1.2 Europe Histamine H4 Receptor Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Histamine H4 Receptor by Product
    • 7.3 Europe Histamine H4 Receptor by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Histamine H4 Receptor by Countries
      • 8.1.1 Asia Pacific Histamine H4 Receptor Sales by Countries
      • 8.1.2 Asia Pacific Histamine H4 Receptor Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Histamine H4 Receptor by Product
    • 8.3 Asia Pacific Histamine H4 Receptor by End User

    9 Central & South America

    • 9.1 Central & South America Histamine H4 Receptor by Countries
      • 9.1.1 Central & South America Histamine H4 Receptor Sales by Countries
      • 9.1.2 Central & South America Histamine H4 Receptor Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Histamine H4 Receptor by Product
    • 9.3 Central & South America Histamine H4 Receptor by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Histamine H4 Receptor by Countries
      • 10.1.1 Middle East and Africa Histamine H4 Receptor Sales by Countries
      • 10.1.2 Middle East and Africa Histamine H4 Receptor Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Histamine H4 Receptor by Product
    • 10.3 Middle East and Africa Histamine H4 Receptor by End User

    11 Company Profiles

    • 11.1 Chrysalis Pharma SAS
      • 11.1.1 Chrysalis Pharma SAS Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Chrysalis Pharma SAS Histamine H4 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Chrysalis Pharma SAS Histamine H4 Receptor Products Offered
      • 11.1.5 Chrysalis Pharma SAS Recent Development
    • 11.2 Griffin Discoveries BV
      • 11.2.1 Griffin Discoveries BV Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Griffin Discoveries BV Histamine H4 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Griffin Discoveries BV Histamine H4 Receptor Products Offered
      • 11.2.5 Griffin Discoveries BV Recent Development
    • 11.3 Johnson & Johnson
      • 11.3.1 Johnson & Johnson Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Johnson & Johnson Histamine H4 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Johnson & Johnson Histamine H4 Receptor Products Offered
      • 11.3.5 Johnson & Johnson Recent Development
    • 11.4 OSE Pharma SA
      • 11.4.1 OSE Pharma SA Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 OSE Pharma SA Histamine H4 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 OSE Pharma SA Histamine H4 Receptor Products Offered
      • 11.4.5 OSE Pharma SA Recent Development
    • 11.5 Palau Pharma, S.A.
      • 11.5.1 Palau Pharma, S.A. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Palau Pharma, S.A. Histamine H4 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Palau Pharma, S.A. Histamine H4 Receptor Products Offered
      • 11.5.5 Palau Pharma, S.A. Recent Development
    • 11.6 Sensorion S.A.
      • 11.6.1 Sensorion S.A. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Sensorion S.A. Histamine H4 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Sensorion S.A. Histamine H4 Receptor Products Offered
      • 11.6.5 Sensorion S.A. Recent Development
    • 11.7 Ziarco Pharma Ltd
      • 11.7.1 Ziarco Pharma Ltd Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Ziarco Pharma Ltd Histamine H4 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Ziarco Pharma Ltd Histamine H4 Receptor Products Offered
      • 11.7.5 Ziarco Pharma Ltd Recent Development

    12 Future Forecast

    • 12.1 Histamine H4 Receptor Market Forecast by Regions
      • 12.1.1 Global Histamine H4 Receptor Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Histamine H4 Receptor Revenue Forecast by Regions 2019-2025
    • 12.2 Histamine H4 Receptor Market Forecast by Product
      • 12.2.1 Global Histamine H4 Receptor Sales Forecast by Product 2019-2025
      • 12.2.2 Global Histamine H4 Receptor Revenue Forecast by Product 2019-2025
    • 12.3 Histamine H4 Receptor Market Forecast by End User
    • 12.4 North America Histamine H4 Receptor Forecast
    • 12.5 Europe Histamine H4 Receptor Forecast
    • 12.6 Asia Pacific Histamine H4 Receptor Forecast
    • 12.7 Central & South America Histamine H4 Receptor Forecast
    • 12.8 Middle East and Africa Histamine H4 Receptor Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Histamine H4 Receptor Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Histamine H4 Receptor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Histamine H4 Receptor market based on company, product type, end user and key regions.

      This report studies the global market size of Histamine H4 Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Histamine H4 Receptor in these regions.
      This research report categorizes the global Histamine H4 Receptor market by top players/brands, region, type and end user. This report also studies the global Histamine H4 Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Chrysalis Pharma SAS
      Griffin Discoveries BV
      Johnson & Johnson
      OSE Pharma SA
      Palau Pharma, S.A.
      Sensorion S.A.
      Ziarco Pharma Ltd

      Market size by Product
      GD-48
      JNJ-28307474
      UR-63325
      ZPL-389
      Others
      Market size by End User
      Asthma
      Cystic Fibrosis
      Atopic Dermatitis
      Hearing Disorders
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Histamine H4 Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Histamine H4 Receptor market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Histamine H4 Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Histamine H4 Receptor submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Histamine H4 Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Histamine H4 Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now